Assessment of the Nicotine Pharmacokinetics When Using Two Types of E-Cigarettes in Healthy Adults Who Smoke: Results From Two Randomized, Crossover Studies Cover

.blurhash-client-img { display: none !important; }

Assessment of the Nicotine Pharmacokinetics When Using Two Types of E-Cigarettes in Healthy Adults Who Smoke: Results From Two Randomized, Crossover Studies

Contributions to Tobacco & Nicotine Research

Volume 33 (2024): Issue 3 (June 2024)

By: Dai Yuki, Lesley Giles, Sylvain Larroque, Sam Harbo, Anthony Hemsley and Javier Martinez

Open Access

|Aug 2024

Authors

Dai Yuki

dai.yuki@jt.com

JT International, Geneva, Switzerland

Japan Tobacco Inc, Tokyo, Japan

Lesley Giles

JT International, Geneva, Switzerland

Sylvain Larroque

JT International, Geneva, Switzerland

Sam Harbo

JT International, Geneva, Switzerland

Anthony Hemsley

JT International, Geneva, Switzerland

Javier Martinez

JT International, Geneva, Switzerland

DOI: https://doi.org/10.2478/cttr-2024-0007 | Journal eISSN: 2719-9509

Journal RSS Feed

Language: English

Page range: 173 - 188

Submitted on: Jan 28, 2024

Accepted on: Apr 24, 2024

Published on: Aug 21, 2024

Published by: Institut für Tabakforschung GmbH

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Clinical study,

nicotine pharmacokinetics

Related subjects:

General interest,

Life sciences, other,

© 2024 Dai Yuki, Lesley Giles, Sylvain Larroque, Sam Harbo, Anthony Hemsley, Javier Martinez, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.

Previous article Volume 33 (2024): Issue 3 (June 2024)